Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Spirometric reference values for Malagasy adults aged 18–73 years

Julia Ratomaharo, Olinto Linares Perdomo, Dave S. Collingridge, Rabezanahary Andriamihaja, Matthew Hegewald, Robert L. Jensen, John Hankinson, Alan H. Morris
European Respiratory Journal 2015 45: 1046-1054; DOI: 10.1183/09031936.00114914
Julia Ratomaharo
1Service de Pneumologie, Hôpital Privé d’Athis-Mons, Athis-Mons, France
7Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olinto Linares Perdomo
2Pulmonary and Critical Care Division, Dept of Medicine, Intermountain Medical Center, Murray, UT, USA
7Both authors contributed equally
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Olinto.linares@imail.org
Dave S. Collingridge
3Office of Research, Intermountain Healthcare, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rabezanahary Andriamihaja
4Service de Pneumologie, Centre Hospitalier Universitaire de Toamasina, Toamasina, Madagascar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Hegewald
2Pulmonary and Critical Care Division, Dept of Medicine, Intermountain Medical Center, Murray, UT, USA
5University of Utah, School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Jensen
2Pulmonary and Critical Care Division, Dept of Medicine, Intermountain Medical Center, Murray, UT, USA
5University of Utah, School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hankinson
6Hankinson Consulting, Inc., Athens, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan H. Morris
2Pulmonary and Critical Care Division, Dept of Medicine, Intermountain Medical Center, Murray, UT, USA
5University of Utah, School of Medicine, Salt Lake City, UT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The American Thoracic Society (ATS) and European Respiratory Society (ERS) recommend that spirometry prediction equations be derived from samples of similar race/ethnicity. Malagasy prediction equations do not exist. The objectives of this study were to establish prediction equations for healthy Malagasy adults, and then compare Malagasy measurements with published prediction equations.

We enrolled 2491 healthy Malagasy subjects aged 18–73 years (1428 males) from June 2006 to April 2008. The subjects attempted to meet the ATS/ERS 2005 guidelines when performing forced expiratory spirograms. We compared Malagasy measurements of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC with predictions from the European Community for Steel and Coal (ECSC), the third National Health and Nutrition Examination Survey (NHANES III) and the ERS Global Lung Function Initiative (GLI) 2012 study.

A linear model for the entire population, using age and height as independent variables, best predicted all spirometry parameters for sea level and highland subjects. FEV1, FVC and FEV1/FVC were most accurately predicted by NHANES III African-American male and female, and by GLI 2012 black male and black and South East Asian female equations. ECSC-predicted FEV1, FVC and FEV1/FVC were poorly matched to Malagasy measurements.

We provide the first spirometry reference equations for a healthy adult Malagasy population, and the first comparison of Malagasy population measurements with ECSC, NHANES III and GLI 2012 prediction equations.

Abstract

Malagasy linear regression predicts spirometry, as do NHANES III and GLI 2012 black and South East Asian equations http://ow.ly/DvUQv

Introduction

The American Thoracic Society (ATS) and the European Respiratory Society (ERS) recommend that reference (prediction) values for pulmonary function tests be obtained from “normal” or “healthy” subjects with similar race/ethnic characteristics wherever possible [1]. In the USA, the ATS-recommended equations are derived from the third National Health and Nutrition Examination Survey (NHANES III) [2]. The NHANES III prediction equations make a clear separation between three subject groups: Caucasian, African-American and Mexican-American. In Europe, the European Community for Steel and Coal (ECSC) reference equations are the most commonly used [3]. The recent ERS Task Force Global Lung Function Initiative (GLI) study 2012 established global spirometric prediction equations for 3–95-year-olds [4, 5] using the GAMLSS (generalized additive models for location, scale and shape) approach [6, 7]. These reference equations are intended to be applied globally across all ethnic groups, both sexes and for ages from 3 to 95 years, although different groups have different age ranges. The GLI 2012 study produced the first multi-ethnic, continuous spirometric prediction equations, and lower/upper limits, for four ethnic groups: Caucasian, Black, South East Asian and North East Asian. Subjects not included in these four ethnic groups were included in “others”, with predictions derived from the average of the four ethnic groups. Note that GLI 2012 black subjects are equivalent to African-Americans because data for GLI 2012 black subjects were taken exclusively from the USA population samples for the Multi-Ethnic Study of Atherosclerosis (MESA) lung study [8], NHANES III [2], NHANES IV [9] and the study by Wang et al. [10]. The GLI 2012 study investigators exerted an extraordinary effort collecting selected data from 33 countries around the world, but had no data from Madagascar [4, 5].

Madagascar is a developing country, where respiratory diseases represent a major public health problem. The Malagasy population of 22 million is composed primarily of Austronesian immigrants from Borneo and black (primarily Bantu) immigrants from Africa. Malagasy, a language of Malaysian roots, is spoken, written and understood in the whole island by the Malagasy population. Because of economic hardship, many people have moved to the cities to find jobs. Poverty-based malnutrition is a large public health problem. The majority of Austronesian immigrants live in the High Plateau (1370 m altitude; highland dwellers) where the weather is temperate and most earn their living through manual labour. The majority of black African immigrants live on the coast (coast dwellers) where the weather is tropical and most earn their living by fishing. The black African immigrant population is not comparable to the African-American group in NHANES III with regard to developmental aspects (nutrition, environment, etc.). Currently, ∼60% of the Malagasy population live in the High Plateau (Merina, Betsileo, Vakinankaratra and Sihanaka people) and 40% live on the coast (Betsimisaraka, Sakalava, Tanala, Tsimihety, Antesaka, Antemoro, Antandroy, Vezo, Bara, Antambahoaka, Antanosy, Mahafaly, Masikoro, Antefasy, Bezanozano and Antakarana people). Currently, about 45% of the population are aged <20 years and only 3% are >65 years. The mean life expectancy is 66.3 years (females 68 years, males 66 years) [11].

Malagasy spirometry prediction equations have not been previously established. The appropriateness of using published prediction equations for other populations to predict Malagasy values has not been evaluated. We intended to: 1) establish spirometric prediction equations for healthy Malagasy adults aged 18–73 years, and 2) compare our Malagasy measurements with predictions from the ECSC [3], NHANES III [2] and GLI 2012 study [4].

Methods

Subjects and testing procedure

We trained four teams of investigators (general practitioner physicians) in Antananarivo, Madagascar’s capital city. We first conducted a workshop focused on chronic obstructive pulmonary disease, asthma, airway obstruction reversibility and lung restriction. In a subsequent workshop we explained the multicentre study intended to account for ethnicity and the lifestyle of the population. We trained the investigators to obtain spirograms with the ZAN100 electronic spirometer, a variable impedance pneumotachometer (EMO International, La Rochelle, France). The general practitioner investigators delivered the questionnaire and performed a chest auscultation for each potential subject.

We sampled 2491 healthy, life-long nonsmoking, non-obese, male and female adult subjects (aged 18–73 years) without a history of respiratory disease (fig. 1). We derived the subject sample from 20 groups in Madagascar: Merina, Betsileo, Vakinankaratra, Sihanaka, Betsimisaraka, Sakalava, Tanala, Tsimihety, Antesaka, Antemoro, Antandroy, Vezo, Bara, Antambahoaka, Antanosy, Mahafaly, Masikoro, Antefasy, Bezanozano and Antakarana. We recruited subjects in the market places, at church after Catholic and Protestant religious services, at companies processing newly hired workers who were required to take medical examinations, among friends and family members of hospitalised patients, and during several “Day of the Breath” events, special events widely advertised by local newspapers, television and radio in Madagascar.

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

Flow diagram of subjects included and excluded, drawn using the CONSORT (Consolidated Standards of Reporting Trials) template.

Subjects attempted to meet the ATS/ERS 2005 guidelines [1] when performing forced expiratory spirograms using the ZAN100 electronic spirometer. We provided the same spirometry method training to all four medical teams in two coastal and two highland (1370 m altitude) centres in Madagascar. We calibrated the spirometers at least daily with a 3-L syringe.

The Malagasy Ethics Committee of the Malagasy Public Health Dept approved the study. Subjects provided informed consent and the following information: age, sex, smoking history, respiratory symptoms, respiratory disease, hypertension, hospitalisation and medication (for the questionnaire, see the online supplementary material). Subjects were excluded if they had respiratory symptoms or disease, any history of smoking, were obese or had malnutrition (body mass index <18.5 or >28 kg·m−2). Minority inhabitants of non-Malagasy origin were excluded (Chinese, Creole, Indian and French).

On the day of examination we measured standing height and weight without shoes with the subjects wearing light clothing. A minimum of three forced expiratory spirograms were obtained for each subject (in a sitting position). We measured forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF), forced expiratory flows at 25%, 50% and 75% of exhaled FVC (FEF25%, FEF50% and FEF75%, respectively), and the forced expiratory flow at 25–75% of exhaled FVC (FEF25–75%).

Statistical analysis

We used a multiple linear regression model to estimate the median and lower limit of normal (LLN) for FEV1, FVC, FEV1/FVC, PEF, FEF25%, FEF50%, FEF75% and FEF25–75%. We compared our Malagasy measured values with predicted values from the ECSC [3], NHANES III [2] and GLI 2012 study [4, 5]. We computed the mean of individual subject differences (percentage of measured value) between measured and predicted values. Z-scores were calculated as (observed-predicted)/sdpred, where sdpred is the standard deviation of the predicted value. sdpred=(predicted-LLN)/1.6445. We compared Z-scores for ECSC [3], NHANES III [2] and GLI 2012 [4, 5] predictions. We only report FVC, FEV1 and FEV1/FVC in this article, because they are the most clinically useful. For analyses of other parameters see the online supplementary material.

We used the R Project for Statistical Computing, version 2.11.1 (www.r-project.org), and MATLAB version R2013b (MATLAB Central File Exchange, www.mathworks.co.uk/matlabcentral/fileexchange). Two investigators (O. Linares Perdomo and D.S. Collingridge) independently confirmed the Malagasy prediction equations and the Z-score computations by independently checking the computer code and duplicating the results.

For comparison purposes, we created male and female FEV1, FVC and FEV1/FVC prediction equations following the GAMLSS approach [6, 7, 12]. We excluded outliers that were at least four standard deviations from the mean (i.e. Z-score of ±4) from the GAMLSS modelling process. Next, we searched for the most parsimonious models by evaluating log–log plots, adding penalised smoothing splines, altering distributions with a log link function (e.g. Box Cox Cole Green, Box Cox Power Exponential), adding log transformations on age and height, and fixing the shape parameter (nu) to 1. Using the Schwarz Bayesian Criteria with a penalty function to prevent over-fitting, we selected the most parsimonious GAMLSS models then created splines, lookup tables, predicted values and standardised residuals for these models.

Results

The questionnaire was completed by 4526 subjects (fig. 1). Questionnaire responses excluded 1519 subjects, leaving 3007 who provided spirograms. A total of 516 subjects with spirograms (17.2% of 3007) were excluded from analysis, with 102 being excluded because they could not perform acceptable or repeatable spirograms and a further 414 being excluded for undocumented reasons after review by a pulmonologist. The final study cohort included 1063 (43%) females and 1428 (57%) males (table 1 and fig. 1). Aggregate values for FEV1, FVC, FEV1/FVC ratio, PEF, FEF25%, FEF50%, FEF75% and FEF25–75% for male and female coast and highland dwellers are shown in supplementary table S1. The coast and highland Malagasy subjects had similar mean FEV1 and FVC values and similar regression equations across the entire age and height range (fig. 2). Small differences in very old subjects did not justify separate regressions and we treated all subjects as members of one homogeneous population.

FIGURE 2
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2

Mean forced expiratory volume in 1 s (FEV1) and mean forced vital capacity (FVC) versus a–d) age and e–h) height for male and female Malagasy coast and highland dwellers.

View this table:
  • View inline
  • View popup
TABLE 1 Demographic data for Malagasy subjects

Age and height were independent variables for all spirometry parameters except FEV1/FVC (for which only age was an independent variable). Male and female prediction equations for FEV1, FVC and FEV1/FVC are shown in table 2. We computed the LLN of the population as the predicted-(1.645×sdresiduals). Prediction equations for the other parameters are shown in supplementary table S2.

View this table:
  • View inline
  • View popup
TABLE 2 Prediction equations for adult Malagasy males and females aged 18–73 years

The GAMLSS residuals were compared with the multiple linear regression analysis residuals (supplementary table S4). The GAMLSS models were not superior to the multiple linear regression models. The likely reason for lack of improvement with GAMLSS modelling is that our Malagasy data are largely linear for individuals aged 18–73 years (fig. 2). Finally, a dichotomous variable representing elevation (highland versus coastal) added to the GAMLSS model was not a significant predictor of FEV1, FVC and FEV1/FVC. For this reason we excluded elevation from our GAMLSS prediction equations.

Comparisons of our data, and the Malagasy multiple linear regression model, with ECSC, NHANES III and GLI 2012 models are presented in table 3 and supplementary table S3. Z-scores comparing our observed Malagasy spirometry data with published prediction equations are shown in figures 3 and 4.

FIGURE 3
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3

Z-scores for a) forced expiratory volume in 1 s (FEV1), b) forced vital capacity (FVC) and c) FEV1/FVC ratio between observed Malagasy values and predicted values using the third National Health and Nutrition Examination Survey (NHANES III) [2] and Global Lung Function Initiative (GLI) 2012 [4] predictions for males. Z-scores were calculated as (observed-predicted)/sdpred, where sdpred is the standard deviation of the predicted value.

FIGURE 4
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4

Z-scores for a) forced expiratory volume in 1 s (FEV1), b) forced vital capacity (FVC) and c) FEV1/FVC ratio between observed Malagasy values and predicted values using the third National Health and Nutrition Examination Survey (NHANES III) [2] and Global Lung Function Initiative (GLI) 2012 [4] predictions for females. Z-scores were calculated as (observed-predicted)/sdpred, where sdpred is the standard deviation of the predicted value.

View this table:
  • View inline
  • View popup
TABLE 3 Differences between individual Malagasy measured values and predictions for FEV1, FVC and FEV1/FVC

Discussion

This study contains important attributes needed for the development of clinically useful reference equations for the Malagasy population, although the study subjects were not randomly selected from the population. The reference subjects were derived from a large sociodemographically representative population, distributed with regard to sex, age, height and ethnic background (highland versus coast dwellers). The population included only life-long nonsmokers and patients without overt cardiac or pulmonary disease. Because spirometry tracings were not saved for independent quality review, it is not possible to determine whether all tests met current ATS/ERS standards (a pulmonologist excluded spirograms of 414 subjects for reasons that were not recorded). However, given the absence of previous data for spirometry prediction equations for Malagasy subjects, the current results provide the best approximate estimate of spirometry predictions for residents of Madagascar. Future studies should further improve our prediction equations. We cannot comment on extrapolation of these reference equations beyond the age range (18–73 years) of our Malagasy data.

We chose to report the simpler multiple linear regression models because the GAMLSS and linear regression models for adults were clinically indistinguishable. We only studied adult subjects aged 18–73 years, an age range that avoids the changes in lung function due to the growing lungs of children.

Comparisons of our measurements with published prediction equations revealed that Malagasy FEV1, FVC and FEV1/FVC can be most accurately predicted, in the aggregate, by NHANES III African-American prediction equations for males and females (table 3 and figs 3 and 4), and by GLI 2012 black predictions for males and black and South East Asian predictions for females (table 3 and figs 3 and 4). ECSC-predicted FEV1 and FVC were poorly matched to Malagasy measurements (table 3).

Conclusion

Within study constraints, we provide the first spirometry reference equations for a healthy adult Malagasy population and the first comparison of Malagasy population measurements with ECSC, NHANES III and GLI 2012 prediction equations. Our study was carried out in a sociodemographically representative population sample. These reference equations are the best available for clinical practice and epidemiological studies in Madagascar. Interestingly, the NHANES III African-American and GLI 2012 black and South East Asian prediction equations (not the “other” group prediction equations) are best matched to Malagasy subjects, regardless of ethnic background.

Acknowledgements

This work was a collaboration between the MaSpiroGroup in Madagascar and the Groupe de Travail des Normes Spirométriques Malgaches (NSM), Pneumalga, France. Members of these groups are as follows. MaSpiroGroup, Madagascar: F. Rakotosihanaka, H. Randrianary, J. Rafaliarisoa and M. Randriantahiry (Centre Hospitalo Universitaire Fenoarivo); R. Andriamihaja and R. Razafinjato (Centre Hospitalier Universitaire de Toamasina); J.M. Ramonja, L. Raholiarisoa and H. Razafiarison (Centre hospitalier de Référence Régional Fianarantsoa); and R. Rakotovao (Clinique Saint-Luc, Toliara). Groupe de Travail des Normes Spirométriques Malgaches, Pneumalga, France: O. Randrianarivelo (Exploration Fonctionnelle Respiratoire Groupe Hospitalier Pitié-Salpêtrière, Paris), D. Rakotonanahary (Hôpital Saint Antoine, Paris), F. Rasolojaona (Cabinet Medical, Provins) and J. Ratomaharo (Service de Pneumologie, Hôpital Privé d’Athis-Mons, Athis-Mons).

Footnotes

  • This article has supplementary material available from erj.ersjournals.com

  • Support statement: This work was supported by Pneumalga (Association des pneumologues d’origine malgache, exerçant en France (Association of Malagasy Pulmonologists working in France); Antony, France), the Intermountain Research and Medical Foundation (Murray, UT, USA), and Intermountain Healthcare (Salt Lake City, UT, USA).

  • Conflict of interest: None declared.

  • Received June 24, 2014.
  • Accepted October 10, 2014.
  • Copyright ©ERS 2015

References

  1. ↵
    1. Pellegrino R,
    2. Viegi G,
    3. Brusasco V, et al.
    Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
    OpenUrlFREE Full Text
  2. ↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB
    . Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179–187.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Quanjer PH,
    2. Tammeling GJ,
    3. Cotes JE, et al.
    Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6 Suppl. 16:5–40.
    OpenUrlFREE Full Text
  4. ↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ, et al.
    Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–1343.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Quanjer PH,
    2. Hall GL,
    3. Stanojevic S, et al.
    Age- and height-based prediction bias in spirometry reference equations. Eur Respir J 2012; 40: 190–197.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Rigby RA,
    2. Stasinopoulos DM
    . Generalized additive models for location, scale and shape. J R Stat Soc Ser C Appl Stat 2005; 54: 507–554.
    OpenUrlCrossRef
  7. ↵
    1. Stasinopoulos DM,
    2. Rigby RA
    . Generalized additive models for location scale and shape (GAMLSS) in R. J Stat Softw 2007; 23: i07.
    OpenUrl
  8. ↵
    1. Hankinson JL,
    2. Kawut SM,
    3. Shahar E, et al.
    Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 2010; 137: 138–145.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    National Health and Nutrition Examination Survey IV (NHANES IV). Hyattsville, National Center for Health Statistics Data Dissemination Branch. http://clinicaltrials.gov/show/NCT00005154 Date last updated: April 13, 2009.
  10. ↵
    1. Wang X,
    2. Dockery DW,
    3. Wypij D, et al.
    Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75–88.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Human Development Report 2013. The Rise of the South: Human Progress in a Diverse World. New York, United Nations Development Programme, 2013. Available from: www.undp.org/content/undp/en/home/librarypage/hdr/human-development-report-2013/.
  12. ↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Stocks J, et al.
    GAMLSS in action: annotated examples of working with R and GAMLSS. Global Lung Function Initiative, 2012. Available from: www.lungfunction.org/gamlss.html
PreviousNext
Back to top
View this article with LENS
Vol 45 Issue 4 Table of Contents
European Respiratory Journal: 45 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spirometric reference values for Malagasy adults aged 18–73 years
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Spirometric reference values for Malagasy adults aged 18–73 years
Julia Ratomaharo, Olinto Linares Perdomo, Dave S. Collingridge, Rabezanahary Andriamihaja, Matthew Hegewald, Robert L. Jensen, John Hankinson, Alan H. Morris
European Respiratory Journal Apr 2015, 45 (4) 1046-1054; DOI: 10.1183/09031936.00114914

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Spirometric reference values for Malagasy adults aged 18–73 years
Julia Ratomaharo, Olinto Linares Perdomo, Dave S. Collingridge, Rabezanahary Andriamihaja, Matthew Hegewald, Robert L. Jensen, John Hankinson, Alan H. Morris
European Respiratory Journal Apr 2015, 45 (4) 1046-1054; DOI: 10.1183/09031936.00114914
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung structure and function
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Viable virus aerosol propagation by PAP circuit leak
  • Ambulatory management of secondary spontaneous pneumothorax
  • Systematic assessment of respiratory health in illness susceptible athletes
Show more Original Articles

Lung function

  • Reference equations for spirometry function tests in South Asia
  • GLI 2017 reference equations and interpretation of TLCO
  • Reference equations for CO and NO diffusing capacity
Show more Lung function

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society